Technical Analysis for ILMN - Illumina, Inc.

Grade Last Price % Change Price Change
grade C 312.75 0.87% 2.70
ILMN closed up 0.87 percent on Friday, January 18, 2019, on approximately normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Jan 29

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Up
See historical ILMN trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Resistance Bearish 0.00%
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Stochastic Reached Overbought Strength 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.87%
Jan 17 Up 3 Days in a Row Strength 0.87%
Jan 16 Shooting Star Candlestick Bearish 2.33%
Jan 16 Doji - Bearish? Reversal 2.33%

Older signals for ILMN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company's sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia's; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Is ILMN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 372.61
52 Week Low 207.51
Average Volume 1,084,889
200-Day Moving Average 303.9762
50-Day Moving Average 313.3156
20-Day Moving Average 298.645
10-Day Moving Average 305.682
Average True Range 11.6509
ADX 11.97
+DI 23.9902
-DI 23.4652
Chandelier Exit (Long, 3 ATRs ) 285.7273
Chandelier Exit (Short, 3 ATRs ) 305.9527
Upper Bollinger Band 319.4395
Lower Bollinger Band 277.8505
Percent B (%b) 0.84
BandWidth 13.925899
MACD Line -1.0011
MACD Signal Line -3.2997
MACD Histogram 2.2985
Fundamentals Value
Market Cap 45.67 Billion
Num Shares 146 Million
EPS 4.98
Price-to-Earnings (P/E) Ratio 62.80
Price-to-Sales 12.23
Price-to-Book 11.20
PEG Ratio 3.91
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 325.48
Resistance 3 (R3) 324.73 319.74 323.36
Resistance 2 (R2) 319.74 316.50 320.11 322.65
Resistance 1 (R1) 316.24 314.49 313.75 316.99 321.94
Pivot Point 311.25 311.25 310.00 311.63 311.25
Support 1 (S1) 307.76 308.01 305.26 308.51 303.56
Support 2 (S2) 302.77 306.01 303.14 302.85
Support 3 (S3) 299.27 302.77 302.14
Support 4 (S4) 300.02